Fidelity Investments
DRUG

Fidelity Investments’s Bright Minds Biosciences DRUG Stock Holding History

Fidelity Investments’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$551K Buy
7,851
+7,032
+859% +$552K ﹤0.01% 3253
2026
Q1 		$59.8K Sell
819
-292
-26% -$23.5K ﹤0.01% 4041
2025
Q4 		$86.7K Buy
1,111
+460
+71% +$30.7K ﹤0.01% 3833
2025
Q3 		$39.5K Buy
651
+572
+724% +$22.2K ﹤0.01% 4083
2025
Q2 		$2.06K Buy
+79
New +$2.37K ﹤0.01% 4857

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Fidelity Investments's DRUG Position: Q2 2026 in Review

Fidelity Investments increased its Bright Minds Biosciences (DRUG) stake by 859% in Q2 2026, buying an estimated $552K and bringing the position to 7,851 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #3253.

Fidelity Investments first reported a position in DRUG in Q2 2025 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Fidelity Investments held 7,851 shares of Bright Minds Biosciences worth $551K as of Q2 2026.
  • Fidelity Investments bought 7,032 Bright Minds Biosciences shares in Q2 2026, an estimated $552K.
  • Bright Minds Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3253 holding.
  • Fidelity Investments first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.